Patent details

Basic Information

Publication number:

EP1668003

PCT Application Number:

PCT/EP/2004/010938

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP047870696

PCT Publication Number:

WO/2005/030763

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Benzisoxazoles

French Title of Invention:

Benzisoxazoles

German Title of Invention:

Benzisoxazole

SPC Number:

Dates

Filing date:

30/09/2004

Grant date:

14/11/2007

EP Publication Date:

14/11/2007

PCT Publication Date:

07/04/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/06/2006

EP B1 Publication Date:

14/11/2007

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

30/09/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/05/2017

 

 

Name:

Vanda Pharmaceuticals Inc.

Address:

2200 Pennsylvania Ave NW Suite 300-E, Washington, DC 20037, United States (US)

History of Owners

From:

30/09/2004

To:

19/05/2017

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:

HOFSTETTER, SCHURACK & PARTNER

From:

05/11/2007

Address:

BALANSTRASSE 57, 81541, MUENCHEN, Germany (DE)

To:

Inventor

1

Name:

NOZULAK Joachim

Address:

Germany (DE)

2

Name:

KALKMAN Hans, O.

Address:

Switzerland (CH)

Priority

Priority Number:

0322994

Priority Date:

01/10/2003

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C07D 413/04;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2017/03

Publication date:

21/07/2017

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20170000172A

Date Registered:

19/05/2017

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

ARONOVA S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Vanda Pharmaceuticals Inc.

Address:

2200 Pennsylvania Ave NW Suite 300-E, Washington, DC 20037, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

27/09/2023

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

Computer Packages INC

Filing date	Document type	Number of pages
19/05/2017	Outgoing Correspondence	1
19/05/2017	Request For Change	3